← Back to catalogue

MammoPad Radiolucent Cushion

FDA UDI

Class II (US FDA UDI)

by Hologic, Inc.

Identity

Trade Name
MammoPad Radiolucent Cushion FDA UDI
Generic Name
Radiological breast positioner, non-wearable FDA UDI
Device Name
The MammoPad® products are designed to provide padding for patient comfort and aid in positioning during radiologic visualization of the breast using x-ray or scintillation technology. FDA UDI
Model / Reference
MP301-10 FDA UDI
Description
The MammoPad® products are designed to provide padding for patient comfort and aid in positioning during radiologic visualization of the breast using x-ray or scintillation technology. FDA UDI

Identifiers

Catalog Number
MP301-10 FDA UDI
Primary DI / UDI-DI
25420045507330 FDA UDI
510(k) Number
K062141 FDA UDI
FDA Product Code
IZH FDA UDI
GMDN Term
Radiological breast positioner, non-wearable FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
892.1710 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Radiological breast positioner, non-wearable

MammoPad Radiolucent Cushion by Hologic, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Radiological breast positioner, non-wearable.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Hologic, Inc.

Sources (1)

  • FDA UDI f8c1b084-4122-45d2-8f87-991fb4a34045 36 fields · synced May 30, 2026